{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "17656142",
  "DateCompleted": {
    "Year": "2008",
    "Month": "01",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2016",
    "Month": "10",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2007",
        "Month": "05",
        "Day": "17"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1286-4579",
      "JournalIssue": {
        "Volume": "9",
        "Issue": "9",
        "PubDate": {
          "Year": "2007",
          "Month": "Jul"
        }
      },
      "Title": "Microbes and infection",
      "ISOAbbreviation": "Microbes Infect"
    },
    "ArticleTitle": "Inoculation of Chlamydia pneumoniae or Chlamydia trachomatis with ligands that inhibit attachment to host cells reduces infectivity in the mouse model of lung infection: implication for anti-adhesive therapy.",
    "Pagination": {
      "StartPage": "1139",
      "EndPage": "1141",
      "MedlinePgn": "1139-41"
    },
    "Abstract": {
      "AbstractText": [
        "Previous studies have shown that the chlamydial glycan contains a high-mannose oligosaccharide, which mediates attachment and infectivity of the organism. Removal of the glycan decreases infectivity in vitro and in vivo. The present study demonstrates that simultaneous inoculation of chlamydial organisms and a ligand that prevents glycan binding reduces lung burden in infected animals."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathobiology, Box 357238, University of Washington School of Public Health and Community Medicine, Seattle, WA 98195-7238, USA. cckuo@u.washington.edu"
          }
        ],
        "LastName": "Kuo",
        "ForeName": "Cho-Chou",
        "Initials": "CC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lee",
        "ForeName": "Amy",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Jiang",
        "ForeName": "Shinn-Jong",
        "Initials": "SJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yaraei",
        "ForeName": "Kambiz",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Campbell",
        "ForeName": "Lee Ann",
        "Initials": "LA"
      }
    ],
    "GrantList": [
      {
        "GrantID": "AI 43060",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Microbes Infect",
    "NlmUniqueID": "100883508",
    "ISSNLinking": "1286-4579"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Acrylic Resins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Ligands"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Mannans"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Oligosaccharides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptor, IGF Type 2"
    },
    {
      "RegistryNumber": "9003-05-8",
      "NameOfSubstance": "polyacrylamide"
    },
    {
      "RegistryNumber": "PHA4727WTP",
      "NameOfSubstance": "Mannose"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Acrylic Resins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Attachment Sites, Microbiological"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Bacterial Adhesion"
    },
    {
      "QualifierName": [
        "metabolism",
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Chlamydia Infections"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "Chlamydia trachomatis"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "Chlamydophila pneumoniae"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ligands"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Lung"
    },
    {
      "QualifierName": [
        "metabolism",
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Lung Diseases"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Mannans"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Mannose"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Animal"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Oligosaccharides"
    },
    {
      "QualifierName": [
        "metabolism",
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Pneumonia, Bacterial"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Receptor, IGF Type 2"
    }
  ]
}